Vedolizumab Injection

DRUG3 trials

Sponsors

Mayo Clinic, Rennes University Hospital, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

Dietary ModificationInflammatory Bowel DiseasesUlcerative Colitis

Early Phase 1

Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.

WithdrawnNCT03309865

Mayo ClinicDietary Modification, Ulcerative Colitis

Start: 2017-12-25End: 2018-12-31Updated: 2018-09-26

Phase 4

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

CompletedNCT03679546

Rennes University HospitalUlcerative Colitis

Start: 2019-01-04End: 2025-06-16Updated: 2025-06-24

Subcutaneous Interval Lengthening of Vedolizumab for Economic Research

RecruitingNCT06584162

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Inflammatory Bowel Diseases

Start: 2023-02-09End: 2026-02-01Target: 40Updated: 2024-09-04